Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2010 Oct;62(10):1473–1480. doi: 10.1002/acr.20237

Table 3.

Relationship between F2-isoprostane Excretion and Clinical Factors in Patients with Rheumatoid Arthritis

Category Factor Rho(ρ)* Unadjusted p-value Adjusted p-value
Age -0.33 <0.001 0.02
BMI 0.35 <0.001 <0.001
HDL Cholesterol 0.04 0.61 0.03
Cardiovascular Risk Factors LDL Cholesterol 0.04 0.56 0.34
Triglycerides 0.01 0.94 0.17
HOMA Index 0.09 0.26 0.55
Framingham Score -0.13 0.10 0.74

Disease Duration -0.03 0.68 0.08
Disease-Related Indices and Inflammatory Mediators DAS28 Index 0.52
0.02 0.75
graphic file with name nihms-207925-t0001.jpg Larsen Score** 0.025 0.75 0.04
graphic file with name nihms-207925-t0002.jpg Neutrophil Count 0.16 0.04 0.51
graphic file with name nihms-207925-t0003.jpg Monocyte Count 0.15 0.06 0.09
graphic file with name nihms-207925-t0004.jpg TNF-α -0.07 0.40 0.78
graphic file with name nihms-207925-t0005.jpg IL-6 0.02 0.82 0.41
graphic file with name nihms-207925-t0006.jpg CRP 0.06 0.41 0.66
graphic file with name nihms-207925-t0007.jpg SAA -0.06 0.47 0.43
*

Univariate Spearman correlation coefficient.

**

n=94.

Adjusted p-values are reported from multiple linear regression models adjusting for age, race, sex, hypertension, BMI and smoking.

log-transformed.